For research use only. Not for therapeutic Use.
GNE-375（Cat No.:I028180）is a selective small molecule inhibitor that targets the enzyme fructose-1,6-bisphosphatase (FBPase), which is involved in gluconeogenesis, the process of glucose production in the liver. By inhibiting FBPase, GNE-375 can reduce glucose production, making it a potential therapeutic agent for managing conditions like type 2 diabetes and metabolic disorders characterized by elevated blood glucose levels. It may also help in preventing hyperglycemia without causing significant hypoglycemia. Ongoing research is focused on evaluating its efficacy, safety, and potential use in metabolic disease management, particularly for improving glucose control.
| CAS Number | 1926989-06-1 |
| Synonyms | 6-[(E)-but-2-enyl]-4-[2,5-dimethoxy-4-(morpholine-4-carbonyl)phenyl]-2-methyl-1H-pyrrolo[2,3-c]pyridin-7-one |
| Molecular Formula | C25H29N3O5 |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
